Status:
COMPLETED
Study of Pulmozyme to Treat Severe Asthma Episodes
Lead Sponsor:
Northwell Health
Collaborating Sponsors:
Genentech, Inc.
Conditions:
Asthma
Eligibility:
All Genders
18-55 years
Phase:
PHASE2
Brief Summary
Even with current standard ED treatments 20-25% of patients presenting to the ED with an acute asthma episode will still require hospitalization. For patients unresponsive to beta-agonists the admit r...
Eligibility Criteria
Inclusion
- acute asthma FEV1\<60% post-standard care age 18-55 years -
Exclusion
- other chronic lung illness pregnancy -
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2006
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT00169962
Start Date
January 1 2004
End Date
September 1 2006
Last Update
October 12 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
LIJMC
Queens, New York, United States, 11040